eDoula App for Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an app called eDoula, designed to provide pregnant patients with information and guidance. The researchers aim to determine if using the app improves labor experiences and satisfaction compared to those who do not use it. Participants will either receive routine care or use the eDoula app during their pregnancy. Individuals who are pregnant for the first time, expecting one baby, speak English, and can use a smartphone may be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance pregnancy experiences for many.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the eDoula App is safe for use during pregnancy?
Research has shown that apps like eDoula are generally safe for users. These apps provide helpful information and guidance during pregnancy and after childbirth, offering reading materials and videos to prepare users for childbirth and the postpartum period.
The eDoula app specifically aims to enhance the pregnancy experience by providing information backed by research, ensuring reliability and trustworthiness. No reports of negative effects have emerged from using these apps, as they primarily offer information.
Although the eDoula app hasn't undergone the usual clinical trial process, its educational focus suggests it is well-received. It's important to note that using an app like eDoula doesn't involve medications or medical procedures, so the risk of physical harm is very low.
Overall, the eDoula app is considered a safe way to access useful pregnancy and postpartum information.12345Why are researchers excited about this trial?
Researchers are excited about the eDoula app because it offers a unique digital support system for pregnant individuals, setting it apart from traditional prenatal care options like in-person consultations and printed educational materials. This app provides on-demand access to personalized pregnancy guidance and resources, potentially enhancing the support network for expecting parents. By leveraging technology, the eDoula app aims to improve both convenience and accessibility, making it easier for users to get the information and assistance they need throughout their pregnancy journey.
What evidence suggests that the eDoula App is effective for pregnancy and postpartum care?
Research has shown that having a doula can greatly improve pregnancy outcomes. Studies have found that doulas can reduce the chance of cesarean births by 39% and lower the risk of early deliveries. In this trial, participants in the eDoula Intervention arm will access the eDoula app, which aims to offer these benefits digitally by providing educational content and support after childbirth. Virtual doula care has also demonstrated benefits for mental health and recognizing important signs of maternal health. By using the eDoula app, participants might experience similar positive effects during and after pregnancy.14678
Who Is on the Research Team?
Fei Cai, MD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
This trial is for first-time pregnant individuals with a single baby, who speak English and own a smartphone or device that can download the eDoula app. They must have delivered at 36 weeks of gestation or later.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment and Baseline
Participants are recruited and surveyed on their labor and satisfaction outcomes
Intervention
Participants in the intervention arm use the eDoula app during pregnancy
Postpartum Follow-up
Participants complete surveys on labor satisfaction and postpartum guidance
What Are the Treatments Tested in This Trial?
Interventions
- eDoula App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor